Inhaled Insulin

Inhaled Insulin
 (Insulin without needles)



In June 2014, the FDA approved Afrezza which is an inhaler with pre-measured, rapid-acting insulin to be used before meals.

Afrezza is not for diabetes emergencies such as diabetic ketoacidosis 糖尿病酮症酸中毒 (DKA).  Common side effects of inhaled insulin are low blood sugar, a cough, and a scratchy or sore throat.

Patients, with smoking habbit or suffering form lung disease, such as asthma or COPD (Chronic obstructive pulmonary disease 慢性阻塞性肺病), shouldn’t use inhaled insulin.

Afrezza     clickhere_orange25

Diabetic ketoacidosis     clickhere_red25

糖尿病酮症酸中毒     clickhere_green25

Chronic obstructive pulmonary disease     clickhere_orange25

慢性阻塞性肺病     clickhere_blue25

Inhalable insulin     clickhere_red25


How Inhaled Insulin Works
With an inhaler similar to the ones used by asthma patients, diabetics breathe a fine insulin powder into lungs.  There, it enters blood through tiny blood vessels.


FDA approval of Afrezza makes evening news


Inhalable Insulin




Leave a Reply